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Introduction: Malignant ischemic stroke of the middle cerebral artery (MCA) territory causes
neurological deterioration due to the effects of space occupying cerebral edema. The
prognosis is poor, and death usually occurs as a result of brainstem compression. There
is no information on ischemic stroke, especially the malignant ones, in patients over 85
years old.
Aim: The aim of this retrospective study was to evaluate the disease course, risk factors,
survival rate and treatment of MCA malignant infarction in people over 85 years old.
Method: The medical history of 66 patients with malignant MCA stroke was analyzed. The
frequency of the occurrence of the risk factors like hypertension, hyperlipidemia, atrial
ﬁbrillation, heart failure, diabetes was evaluated. Disability was measured with the use of
the National Institutes of Health Stroke Scale (NIHSS). Safety and effectiveness of the
anticoagulants used in the group of patients with atrial ﬁbrillation were analyzed. Chi-
quadrat test and Mann–Whitney U test were used for statistical analysis of data. We also
described 85 year-old patient with malignant brain stroke who was treated neurosurgically
with a positive effect.
Results: Atrial ﬁbrillation was diagnosed in 65% of patients of the investigated group. There
were no statistically signiﬁcant changes in the survival rate between the group of patients
treated with the use of mannitol and patients without this treatment.
Conclusion: The key risk factor in this group is the atrial ﬁbrillation. The elderly patients
require an intensive monitoring of the health condition by reference to brain stroke risk
factors, especially atrial ﬁbrillation.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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cerebral artery (MCA) stroke. It is a neurological deterioration
caused by the severe cerebral edema. The malignant stroke
manifests itself in hemiparesis, gaze deviation, headache,
vomiting and disturbances of consciousness. That malignant
edema usually develops one to several days after the stroke [1].
Treatment is often ineffective, the prognosis is still poor, the
survival rate is low and among patients who survived there are
many people with severe disabilities. There is a lack of
publications related to the ischemic strokes – especially the
malignant ones – in people over 85 years old. The incidence of
the ischemic stroke increases with age. The risk of the brain
stroke is twice higher in case of people over 80 years old than in
case of people aged 60–79 [2]. Within the next 20 years, the
incidence of stroke is expected to increase by about 100% [3,4].
The malignant edema develops in case of 10–15% of patients
with MCA ischemic stroke. The mortality rate in this group is
about 80% [1,5,6]. The prevalence of the malignant ischemic
edema in the group of people over 85 years old is not accurately
determined. Moreover, there is no information on the risk
factors of ischemic stroke in people over 85 years old. The
European population is getting older and this problem
becomes more relevant [2,7,8]. Edema caused by the malignant
infarction leads to intracranial pressure increase, reduction of
the cerebro-spinal ﬂuid circulation and blood ﬂow in brain
vessels, ﬁnally leading to compression of the brain stem and
death [9]. If the normal cerebral blood ﬂow is reduced and falls
below a certain level, the reversible functional failure occurs
leading to the morphological damage of neurons [10].
Appropriate treatment of the ischemic stroke, if applied fast,
can give a chance to save a brain tissue called penumbra. Due
to the lower blood ﬂow, in this area of brain, the neurons'
functions are disabled but the apoptosis does not occur [11,12].
The risk factors of the ischemic brain stroke in people over 85
years old remain elusive and they are even less known in case
of malignant strokes.
The aim of this retrospective study was to evaluate the
disease course, risk factors, survival rate and treatment of
MCA malignant infarction in people over 85 years old. The
presented study also concerned the case of 85 year-old patient
with malignant ischemic stroke treated neurosurgically with a
positive effect. Better knowledge of the malignant ischemic
stroke in patients in this age group can contribute to the
improvement of prophylaxis and treatment strategy.
1. Method
The medical history of 66 patients (M 13, W 53) with malignant
MCA stroke (infraction of >50% MCA territory) was analyzed.Table 1 – Correlation between NIHSS score on admission to th
Death in 30 days N 
NIHSS on admission No 30 
Yes 36 
NIHSS on discharge No 30 
Yes 36 
where n denotes number of patients, data are shown as mean value (M)The patients were at the age from 85 to 102 years old (the
average age: 89 years old, SD 4 years). The agreement of
Bioethical Committee in Military Institute of Medicine was
obtained for this study. Thrombolytic therapy, osmotic
treatment or only anti-platelet agents were used in investi-
gated group. One patient was treated neurosurgically. The
frequency of risk factors like hypertension, hyperlipidemia,
atrial ﬁbrillation, heart failure, diabetes was evaluated in all
patients. Severity of the disease and disability were measured
with the use of The National Institutes of Health Stroke Scale
(NIHSS). Computer tomography (CT) of brain, ultrasonography
of carotid arteries and laboratory tests were also evaluated.
Safety and effectiveness of anticoagulants used in the group of
patients with atrial ﬁbrillation were analyzed. The survival
rate and the most frequent complications following hospitali-
zation were evaluated. The neurological status measured with
the use of NIHSS scale and survival rate were evaluated both in
the group of people treated with mannitol and in the group of
people without this treatment. Chi-quadrat and Mann–
Whitney U tests were used to perform the statistical analysis
of data.
2. Results
In the investigated group, 6% of patients after stroke were
diagnosed with the spontaneous hemorrhagic transformation.
In case of 7 patients, the thrombolytic treatment was applied.
In case of 53% of patients, the malignant edema occurred on
the ﬁrst day of hospitalization. In case of 23 patients, the
ultrasonography examination was performed. Clinically sig-
niﬁcant carotid artery stenosis was observed in case of one
patient. In case of 60% of patients the mannitol was
administered and 40% of patients did not obtain that
treatment. NIHSS score on admission to the hospital, in the
group of patients that survived 30 days, was 17.80 (SD 2.85)
points and in the group of patients that died in the ﬁrst month
was 18.03 (SD 3.64) points. There was no statistical correlation
between NIHSS on admission and survival rate (Table 1).
In the investigated group, 26% of patients had abnormal
level of HDL, the same number of patients had abnormal level
of total cholesterol and the LDL level of 18% of patients was too
high. The abnormal level of triglyceride was observed in case
of 8% of patients (Table 2).
The most frequent risk factor diagnosed before the
occurrence of the brain stroke was the hypertension (present
in case of 58% of patients). Heart failure was observed in case of
44% of patients and atrial ﬁbrillation in case of 41% of patients.
Diabetes was present in case of 24% of patients in the
investigated group, while 14% of patients had suffered frome hospital and survival rate.
M SD Min Max
17.80 2.85 8 24
18.03 3.64 9 25
17.17 3.25 8 24
18.97 3.42 10 25
+/- SD.
Table 2 – Lipid profile abnormalities in patients with malignant ischemic stroke.
Normal values Abnormal values No information
n % N % n %
Total cholesterol (<200 mg/dl) 44 66.67 12 18.18 10 15.15
LDL cholesterol (<135 mg/dl) 41 62.12 12 18.18 13 19.70
HDL cholesterol (>35 mg/dl – M; >40 mg/dl – K) 36 54.55 17 25.76 13 19.70
Triglycerides (<150 mg/dl) 50 75.76 5 7.58 11 16.67
Where n denotes number of patients, data are shown as mean value (M) +/ SD.
Table 3 – Occurrence of atrial fibrillation in people over 85 years old with malignant ischemic stroke.
AF Number of patients Percentage
AF diagnosed before admission to hospital 27 40.91
AF diagnosed during hospitalization 16 24.24
Total 43 65.15
Table 4 – Correlation between AF and NIHSS on admis-
sion to the hospital.
FA N M SD P
NIHSS on admission No 23 18.43 3.60 0.568
Yes 43 17.65 3.11
Where n denotes number of patients, data are shown as mean
value (M) +/ SD.
Table 5 – Correlation between survival rate and treatment
with the use of mannitol.
Death in 30 of
hospitalization
Treatment Total
With
mannitol
Without
mannitol
n %
N % n %
No 20 54.05 8 33.33 28 45.90
Yes 17 45.95 16 66.67 33 54.10
Total 37 100.00 24 100.00 61 100.00
Where n denotes number of patients, data are shown as mean
value (M) +/ SD.
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was diagnosed in case of 9% of people. The transient ischemic
attack was diagnosed in case of 8% of patients (in case of 80% it
occurred in the last year). Only 6% of patients were treated due
to hyperlipidemia. Three percent of patients underwent the
ischemic heart attack, while 2% of people were diagnosed with
the chronic renal failure.
The most frequent risk factor of the ischemic stroke
diagnosed during hospitalization was AF which occurred in
case of 24% of patients. The congestive heart failure was
diagnosed in case of 14% of patients in the investigated group,
while hyperlipidemia in case of 12% of patients. Hypertension
was present in case of 3% of patients and diabetes in case of 2%
of patients. Atrial ﬁbrillation was diagnosed in case of 65% of
patients in the investigated group. In case of 41% of patients, it
was diagnosed before the stroke, while in case of 24% of
patients it was diagnosed during hospitalization in the
neurology department caused by the stroke (Table 3).
Among 41% of patients with atrial ﬁbrillation diagnosed
before their admission to the hospital only 5 people had taken
anticoagulants (vitamin K antagonists) and one person had
taken dabigatran. None of the patients in that group had
therapeutic INR (between 2.0 and 3.0).
Moreover, there was no statistical correlation between
NIHSS score on admission in the group of patients with AF and
those without this disease (Table 4).
The Chi-quadrat test did not reveal any statistically
signiﬁcant differences between survival rate in the group of
patients with atrial ﬁbrillation and in patients without this
disease ( p = 0.423).
In case of 55% of patients, death occurred during the ﬁrst
month of hospitalization. Among those patients the average
survival time was from 2 to 30 days and the average life
duration was 11 days (SD 9 days).
The most frequent complication of hospitalization was
urinary tract infection occurring in case of 30% of patients.
Pneumonia was less common – 23%; 14% of patients suffered
from the acute respiratory insufﬁciency and 11% of patients
were diagnosed with the chronic renal failure. Seizures were
present in case of 11% of patients and deep vein thrombosis was
diagnosed in case of 6% of patients in the investigated group.The correlation between administration of mannitol and
survival rate was checked with the use of chi-quadrat test
(Table 5). The statistical analysis revealed that there were no
statistically signiﬁcant changes in the survival rate between
the group of people who were treated with mannitol and
patients who did not obtain this kind of treatment ( p = 0.113).
Statistical analysis performed with the use of Mann–
Whitney U test did not reveal any correlation between the
mannitol treatment and ﬁnal NIHSS score (Table 6).
3. Discussion
The impact of factors such as male sex, cardiovascular disease,
diabetes, hyperlipidemia on the risk of developing the
ischemic brain stroke in people over 85 years old remains
Table 6 – Correlation between mannitol treatment and
NIHSS in stroke survivors at the end of hospitalization.
Treatment N M SD P
NIHSS on discharge With mannitol 20 16.20 3.35 0.011
Without mannitol 8 19.38 2.20
Where n denotes number of patients, data are shown as mean
value (M) +/ SD.
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general health status was poor due to coexistence of dementia,
lack of family and medical care. Multiple organ failure often
leads to polypharmacy. Patients very often do not take
medicines regularly, they have problems with daily activity
and access to medical care [14]. One of the most important risk
factors of the brain stroke, in addition to hypertension, is atrial
ﬁbrillation [15,16]. Given the asymptomatic and undiagnosed
AF, the estimated occurrence of this disease in the general
population is 1.5–2% but in case of people over 85 years old, it
reaches 20% and it is more frequent in case of women [17,18].
Due to the increased occurrence of the atrial ﬁbrillation in
patients over 85 years old, it seems that this group could
beneﬁt most from the use of anticoagulants, however, the risk
of hemorrhagic complications related to taking these medi-
cines is higher compared to younger patients. In the presented
study the most common risk factors of brain stroke in the
investigated group were hypertension and atrial ﬁbrillation.
Atrial ﬁbrillation was diagnosed in case of 65% of patients in
the investigated group; in case of 41% of patients it was
diagnosed before the occurrence of the stroke, while in case of
24% of patients it was diagnosed during hospitalization in the
neurology department caused by stroke. Among 41% of
patients with atrial ﬁbrillation diagnosed before admission
to the hospital, only 5 people had taken anticoagulants
(vitamin K antagonists) and one person had taken dabigatran.
None of the patients in that group had therapeutic INR
(between 2.0 and 3.0). This proves that medical care in this
group was poor and should be more intensive, especially in
prophylaxis and diagnosis procedures. Furthermore, when
anticoagulants are administered properly, medical care and
monitoring of INR should be performed. It seems that this
group of patients can beneﬁt more from the above-mentioned
treatment but, on the other hand, patients in this group are
exposed to higher risk of hemorrhagic complications.
Malignant middle cerebral artery (MCA) infarctions still
constitute one of the most life-threatening and destructive
forms of ischemic stroke. Computer tomography (CT) and
magnetic resonance imaging (MRI) can help reach an early
diagnosis as well as predict a malignant course of the disease
[19]. In addition, CT is crucial for the exclusion of other causes
of the deterioration of neurological status. The ﬁrst symptom
of ischemic stroke that can be observed in CT is inability to
differentiate the gray-white matter at the cortex level. If these
changes cover over 50% of the MCA territory, it is possible to
predict the malignant infarction with a speciﬁcity of 94%
[1,20,21]. Furthermore, an extent of infarction can be used to
predict the malignant course of disease. The infarction volume
of >220 ml observed in CT and of >145 ml observed in MRI
(DWI sequence) indicates a severe brain edema and herniation
[1,22,23]. Development of CT perfusion, PET, SPECT cancontribute to the establishment of earlier diagnosis of
malignant edema, however, the qualiﬁcation of patients for
surgery is performed according to classic CT and MRI.
Hemicraniectomy, hypothermia and pharmacological therapy
are used in malignant ischemic stroke treatment [1]. In case of
53% of patients covered by the presented study, the malignant
edema was observed in CT images performed on admission to
the hospital, on the ﬁrst day of disease. In other cases the
neurological status deteriorated in the ﬁrst few days of disease
and for this reason control CT was performed revealing the
occurrence of malignant edema. The important question is
therefore whether the earlier image diagnostics performed
before deterioration of the neurological status and before
development of the malignant edema would improve the
treatment outcomes in this group.
Pharmacological treatment is related to the osmotic
therapy with the use of mannitol, glycerol, hypertonic saline
solutions. In spite of the fact that they reduce existing edema
and minimize tissue shifts, they do not signiﬁcantly improve
the outcome [24,25]. In addition, the steroids also proved to be
ineffective [25]. The osmotic therapy causes many side effects
in people over 85 years old, such as acute renal failure,
intensiﬁcation of heart failure, pulmonary edema, hypotony,
and this kind of therapy is still controversial [26]. In case of our
study, the osmotic therapy with the use of mannitol did not
improve the survival rate. Both in the group treated and
untreated with this medicine, the mortality was high (about
50%). On the other hand, in the group of people treated with
mannitol, who survived ﬁrs 30 days of the disease, the ﬁnal
NIHSS score was a little bit lower than in the untreated group.
In case of patients treated pharmacologically, the mortality
rate is high and amounts to about 80% [27]. In our study, almost
half of patients died during the ﬁrst month of hospitalization,
despite the pharmacological treatment. Moreover, there was
no correlation between the survival rate and the occurrence of
atrial ﬁbrillation or lipid proﬁle. There was no correlation
between disease severity measured with NIHSS score and
mean time of survival.
Due to the fact that the pharmacological treatment is
usually ineffective, neurosurgical treatment was introduced
about 30 years ago [28,29]. The European Stroke Organization
developed the guidelines for hemicraniectomy to perform
operations on people aged 18–60 suffering from MCA occlusion
ischemic stroke with malignant edema and severe neurologi-
cal status deterioration (NIHSS higher than 15 points),
disturbances of consciousness, ischemic stroke (covering over
50% of MCA territory). It is very important to perform the
surgery during the ﬁrst 48 h after the occurrence of stroke [29].
In spite of the fact that people who qualiﬁed for the surgical
treatment were between 18 and 60 years old, 85 year-old
woman in the investigated group was operated on with the
satisfactory effect. The family of this patient found her
unconscious lying on the bedroom ﬂoor. She was treated
due to hypertension. Before stroke patient was independent.
The disturbances of consciousness, global aphasia and right
limbs paresis were observed on admission to the hospital. CT
scan revealed large ischemic loci with secondary hemorrhage
in the left MCA territory. On the ﬁfth day of hospitalization, the
CT scan was repeated due to neurological status deterioration
and increasing consciousness deterioration, and revealed
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patient was operated on and the hemicraniectomy was
performed. During the next few days the neurological status
improved, the patient started to say a few words and was able
to perform commands. In the neurology department, the
patient was diagnosed with Clostridium difﬁcile gastrointesti-
nal infectious but after treatment with vancomycin the patient
recovered. The ultrasonography examination of carotid arter-
ies did not show any abnormalities. After two weeks in the
hospital, the patient was discharged and admitted to
rehabilitation department. The patient was operated on the
ﬁfth day of hospitalization, which was also quite unusual and
after the surgery, the neurological status of patient improved.
In case of patients under 60 years old, currently, the
hemicraniectomy constitutes a routine treatment for the
clinical management of malignant MCA infarction but the
presented study conﬁrms that the indications for decom-
pressive surgery need to be individually investigated. Howev-
er, there are still some important questions concerning the
individual indications for decompressive surgery that need to
be resolved. The ideal timing for hemicraniectomy, a potential
cut-off age for the procedure constitute the most important
questions [19]. Two European randomized, multicenter,
controlled trials were performed to investigate the effective-
ness and safety of hemicraniectomy in malignant ischemic
infarct [6,11]. In the ﬁrst trial made in France, called DECIMAL,
the number of patients with moderate disability increased by
more than half due to early decompressive craniectomy which
also signiﬁcantly reduced the mortality in the group of 38
investigated patients [30]. Next study called DESTINY made in
Germany covered 32 patients and showed that early
hemicraniectomy was effective and patients had better
functional outcome as well as survival rate [6]. In DECIMAL
study the number of deaths was about 50% lower in the group
of people treated with hemicraniectomy when compared to
control group which did not obtain this treatment. Moreover,
the number of patients with delicate and moderate disability
was about 50% lower than in control group [6]. In HAMLET
study, the number of patients who died as a result of
malignant stroke was about 38% lower when compared to
healthy controls [31]. Both trails covered patients under 60
years old. However, as regards the older patients, the results
cannot be generalized and there are no sufﬁcient information
about the beneﬁts of the procedure in the elderly population.
The ﬁnal results of the DESTINY II study conﬁrm that
decompressive hemicraniectomy contributes to the increase
of the survival rate without the occurrence of severe disability
in patients aged 61 or older who suffered from brain swelling
after a malignant middle cerebral artery stroke. In this study
112 patients aged on average 70 years old took part in that
study [11,32]. Unfortunately, there are no studies evaluating
hemicraniectomy effectiveness and safety in case of people
over 85 years old with malignant ischemic infarction. On the
other hand, another study revealed that the age exceeding 50
years and the male gender were associated with a high death
risk in case of patients with malignant ischemic stroke [33].
Similar results were presented in another study in which
patients over 60 years old were operated for malignant MCA
infarction [34]. Mortality rate in case of patients with
malignant ischemic stroke was different depending on thetime which has elapsed since the operation and after 3 months
it was 8% and after year 44%. The risk is higher in case of older
patients and when other ischemic loci in brain are present [27].
Hemicraniectomy in malignant brain stroke infraction is a
procedure accepted by Polish Neurological Company as well as
European Stroke Organization and American Brain Stroke
Company [1,35]. Due to the fact that a great amount of patients
with the large ischemic stroke is older than 60 years and the
beneﬁts from the surgery in this group remain unclear, further
scientiﬁc investigations are extremely necessary to determine
the real value of the surgical procedure in elderly people [11]. In
case of patient covered by the presented study, hemicraniec-
tomy was performed successfully despite the fact that it was
carried out on the ﬁfth day after the occurrence of stroke. It
means that the indications for this procedure should be
considered individually and that even patients over 85 years
old can beneﬁt from hemicraniectomy.
Another important issue concerning treatment of people
with the brain stroke belonging to the above-mentioned age
group, is the effectiveness and safety of thrombolysis. In one of
the studies, 6 patients with ischemic brain stroke aged over 80
years old received thrombolysis. In this group, no signiﬁcant
long-term impact on the mortality was reported. Nevertheless,
the number of patients was very small and studies performed
in larger group need to be evaluated. In case of thrombolysis,
the age should not be the decisive factor for disqualiﬁcation of
patients from such treatment but there is still lack of
information about this treatment in case of very old people
[10]. The impact on survival rate and neurological status in
patients with malignant infarct also remains elusive. Among
seven patients treated with thrombolysis under the presented
study, 4 people died within ﬁrst 30 days after the stroke.
Among people who survived, only in case of one person a little
improvement of neurological status (of 1 point in NIHSS score)
was observed but this patient was still severely disabled.
Another option for treatment in patients with malignant
ischemic stroke is hypothermia. Hypothermia reduces post-
ischemic hyperperfusion, blood–brain barrier disruption and
brain edema in animal models and therefore the neurons
apoptosis is minimized in the area of penumbra [36]. In
addition, it can reduce mortality caused by malignant
infarction to 44% but it is still less effective than decom-
pressive hemicraniectomy [37]. On the other hand another
study revealed that hypothermia can reduce effectiveness of
thrombolytic treatment [38,39]. According to this data,
hypothermia can be useful when it accompanies pharmaco-
logical and neurosurgical treatment but further studies
evaluating its effectiveness and safety need to be performed.
Especially, safety and effectiveness of hypothermia in the
above-mentioned age group should be veriﬁed as there are no
studies evaluating this problem.
Malignant middle cerebral artery infarction is a life
threatening event characterized by high mortality. Older
people are in the group of high risk of ischemic stroke,
including the malignant ones. Many problems related to risk
factors proﬁle, proper therapy, indications to neurosurgical
treatment, safety and effectiveness of hypothermia in this age
group need to be resolved. Moreover, obtaining more informa-
tion on the malignant ischemic stroke in people over 85 years
old is necessary to develop better prophylaxis and treatment
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year-old patients who successfully underwent the surgery due
to malignant brain edema. This case shows that the indica-
tions to hemicraniectomy in case of very old patients need to
be analyzed individually because even very old people can
beneﬁt from this procedure.
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